CLPT logo

ClearPoint Neuro (CLPT) Cash From Operations

Annual CFO

-$13.72 M
+$2.45 M+15.14%

December 31, 2023


Summary


Performance

CLPT Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLPTcash flowmetrics:

Quarterly CFO

-$1.20 M
+$1.47 M+55.06%

September 30, 2024


Summary


Performance

CLPT Quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLPTcash flowmetrics:

TTM CFO

-$8.88 M
+$597.00 K+6.30%

September 30, 2024


Summary


Performance

CLPT TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCLPTcash flowmetrics:

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

CLPT Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+15.1%+33.2%+43.2%
3 y3 years-75.7%+63.6%+23.1%
5 y5 years-196.3%-24.4%-211.4%

CLPT Cash From Operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-8.1%+15.1%-2.6%+78.9%at high+49.8%
5 y5-year-381.4%+15.1%-157.1%+78.9%-211.4%+49.8%
alltimeall time-381.4%+15.1%-157.1%+78.9%-371.1%+49.8%

ClearPoint Neuro Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2024
-
-$1.20 M(-55.1%)
-$8.88 M(-6.3%)
Jun 2024
-
-$2.67 M(-30.5%)
-$9.47 M(-20.3%)
Mar 2024
-
-$3.84 M(+228.5%)
-$11.88 M(-13.4%)
Dec 2023
-$13.72 M(-15.1%)
-$1.17 M(-34.9%)
-$13.72 M(-12.1%)
Sep 2023
-
-$1.80 M(-64.6%)
-$15.62 M(-11.6%)
Jun 2023
-
-$5.08 M(-10.7%)
-$17.67 M(+0.5%)
Mar 2023
-
-$5.68 M(+85.3%)
-$17.58 M(+8.7%)
Dec 2022
-$16.17 M(+27.3%)
-$3.06 M(-20.4%)
-$16.17 M(-2.9%)
Sep 2022
-
-$3.85 M(-22.7%)
-$16.65 M(+3.5%)
Jun 2022
-
-$4.98 M(+16.7%)
-$16.10 M(+8.5%)
Mar 2022
-
-$4.27 M(+20.2%)
-$14.84 M(+16.8%)
Dec 2021
-$12.70 M(+62.6%)
-$3.55 M(+7.8%)
-$12.70 M(+10.0%)
Sep 2021
-
-$3.30 M(-11.4%)
-$11.55 M(+20.1%)
Jun 2021
-
-$3.72 M(+74.5%)
-$9.62 M(+26.4%)
Mar 2021
-
-$2.13 M(-11.2%)
-$7.61 M(-2.6%)
Dec 2020
-$7.81 M(+173.9%)
-$2.40 M(+75.6%)
-$7.81 M(+32.9%)
Sep 2020
-
-$1.37 M(-20.0%)
-$5.87 M(+7.4%)
Jun 2020
-
-$1.71 M(-26.7%)
-$5.47 M(+19.6%)
Mar 2020
-
-$2.33 M(+399.9%)
-$4.57 M(+60.4%)
Dec 2019
-$2.85 M(-38.5%)
-$466.30 K(-51.6%)
-$2.85 M(-3.9%)
Sep 2019
-
-$964.10 K(+19.0%)
-$2.97 M(-0.4%)
Jun 2019
-
-$810.10 K(+32.9%)
-$2.98 M(-9.2%)
Mar 2019
-
-$609.50 K(+4.7%)
-$3.28 M(-29.2%)
Dec 2018
-$4.63 M
-$582.40 K(-40.3%)
-$4.63 M(-20.1%)
Sep 2018
-
-$975.30 K(-12.3%)
-$5.79 M(-10.9%)
Jun 2018
-
-$1.11 M(-43.3%)
-$6.50 M(-1.6%)
DateAnnualQuarterlyTTM
Mar 2018
-
-$1.96 M(+12.3%)
-$6.61 M(+10.3%)
Dec 2017
-$5.99 M(+3.0%)
-$1.75 M(+3.8%)
-$5.99 M(+11.8%)
Sep 2017
-
-$1.68 M(+37.9%)
-$5.36 M(+5.2%)
Jun 2017
-
-$1.22 M(-9.4%)
-$5.09 M(-8.4%)
Mar 2017
-
-$1.35 M(+21.1%)
-$5.56 M(-4.5%)
Dec 2016
-$5.82 M(-32.6%)
-$1.11 M(-21.5%)
-$5.82 M(-3.4%)
Sep 2016
-
-$1.42 M(-15.9%)
-$6.03 M(-3.0%)
Jun 2016
-
-$1.68 M(+4.7%)
-$6.21 M(-16.6%)
Mar 2016
-
-$1.61 M(+22.1%)
-$7.45 M(-13.8%)
Dec 2015
-$8.64 M(+19.1%)
-$1.32 M(-17.8%)
-$8.64 M(-7.3%)
Sep 2015
-
-$1.60 M(-45.1%)
-$9.31 M(-5.8%)
Jun 2015
-
-$2.92 M(+4.2%)
-$9.89 M(+13.8%)
Mar 2015
-
-$2.80 M(+40.4%)
-$8.69 M(+19.9%)
Dec 2014
-$7.25 M(-6.8%)
-$1.99 M(-8.3%)
-$7.25 M(+7.1%)
Sep 2014
-
-$2.18 M(+26.3%)
-$6.77 M(+5.3%)
Jun 2014
-
-$1.72 M(+26.7%)
-$6.43 M(-6.7%)
Mar 2014
-
-$1.36 M(-10.2%)
-$6.89 M(-11.4%)
Dec 2013
-$7.78 M(+4.6%)
-$1.51 M(-17.5%)
-$7.78 M(-8.4%)
Sep 2013
-
-$1.84 M(-16.0%)
-$8.49 M(-1.4%)
Jun 2013
-
-$2.19 M(-2.5%)
-$8.61 M(+10.5%)
Mar 2013
-
-$2.24 M(+0.7%)
-$7.79 M(+4.8%)
Dec 2012
-$7.43 M(+19.1%)
-$2.23 M(+13.9%)
-$7.43 M(+42.8%)
Sep 2012
-
-$1.95 M(+42.9%)
-$5.21 M(+60.1%)
Jun 2012
-
-$1.37 M(-27.4%)
-$3.25 M(+72.6%)
Mar 2012
-
-$1.88 M
-$1.88 M
Dec 2011
-$6.24 M(-19.0%)
-
-
Dec 2010
-$7.71 M
-
-

FAQ

  • What is ClearPoint Neuro annual cash flow from operations?
  • What is the all time high annual CFO for ClearPoint Neuro?
  • What is ClearPoint Neuro annual CFO year-on-year change?
  • What is ClearPoint Neuro quarterly cash flow from operations?
  • What is the all time high quarterly CFO for ClearPoint Neuro?
  • What is ClearPoint Neuro quarterly CFO year-on-year change?
  • What is ClearPoint Neuro TTM cash flow from operations?
  • What is the all time high TTM CFO for ClearPoint Neuro?
  • What is ClearPoint Neuro TTM CFO year-on-year change?

What is ClearPoint Neuro annual cash flow from operations?

The current annual CFO of CLPT is -$13.72 M

What is the all time high annual CFO for ClearPoint Neuro?

ClearPoint Neuro all-time high annual cash flow from operations is -$2.85 M

What is ClearPoint Neuro annual CFO year-on-year change?

Over the past year, CLPT annual cash flow from operations has changed by +$2.45 M (+15.14%)

What is ClearPoint Neuro quarterly cash flow from operations?

The current quarterly CFO of CLPT is -$1.20 M

What is the all time high quarterly CFO for ClearPoint Neuro?

ClearPoint Neuro all-time high quarterly cash flow from operations is -$466.30 K

What is ClearPoint Neuro quarterly CFO year-on-year change?

Over the past year, CLPT quarterly cash flow from operations has changed by +$597.00 K (+33.24%)

What is ClearPoint Neuro TTM cash flow from operations?

The current TTM CFO of CLPT is -$8.88 M

What is the all time high TTM CFO for ClearPoint Neuro?

ClearPoint Neuro all-time high TTM cash flow from operations is -$1.88 M

What is ClearPoint Neuro TTM CFO year-on-year change?

Over the past year, CLPT TTM cash flow from operations has changed by +$6.74 M (+43.16%)